Octagon Capital Advisors’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,673,750
| Closed | -$63.2M | – | 64 |
|
|
2023
Q4 | $63.2M | Sell |
2,673,750
-400,000
| -13% | -$9.45M | 10.1% | 2 |
|
|
2023
Q3 | $45.8M | Sell |
3,073,750
-1,497,168
| -33% | -$22.3M | 7.04% | 3 |
|
|
2023
Q2 | $50.1M | Hold |
4,570,918
| – | – | 6.96% | 3 |
|
|
2023
Q1 | $39.9M | Buy |
4,570,918
+2,711,718
| +146% | +$23.6M | 5.73% | 4 |
|
|
2022
Q4 | $11.7M | Buy |
+1,859,200
| New | +$11.7M | 1.82% | 14 |
|